About EvolveGene
EvolveGene is a company based in St. Petersburg (United States) founded in 2015 by Ami Mezezi was acquired by CooperSurgical in April 2018. EvolveGene operates in a competitive market with competitors including MedGenome, Foundation Medicine, Personalis, Veritas Genetics and Burning Rock, among others.
- Headquarter St. Petersburg, United States
- Founders Ami Mezezi
- SectorsHealthcare
- Website evolvegene.com
- Social LinkedIn X Facebook
- Acquired by CooperSurgical (Apr 2018)
- Investors
- Acquired byCooperSurgical
(Apr 2018)
Investors in EvolveGene
EvolveGene has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include CooperSurgical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Offers medical devices for fertility, contraception, and women's health care globally. | 1990 | coopersurgical.com | Trumbull, United States |
Investor details for EvolveGene
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of EvolveGene
1 people are tracked at EvolveGene (1 in leadership).
| Name | Role | Group |
|---|---|---|
Ami Mezezi | Co-Founder | Leadership |
Complete people profiles for EvolveGene
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of EvolveGene
2 dated milestones of EvolveGene across 3 years, from founding to its latest funding, stage changes and deals.
- Founded EvolveGene is founded.
- Exit Acquired by CooperSurgical.
Competitors of EvolveGene
EvolveGene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MedGenome, Foundation Medicine, Personalis, Veritas Genetics and Burning Rock, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medgenome.com | 2013 | Bengaluru, India | $264.5M | 922 | DNA sequencing, bioinformatics, and multiomics services are provided. | |
| foundationmedicine.com | 2010 | Cambridge, United States | $96.5M | 1,707 | Genomics-based diagnostic tests for cancer are provided. | |
| personalis.com | 2011 | Menlo Park, United States | $87.3M | 310 | Genomic sequencing and diagnosis software is provided for healthcare. | |
| veritasgenetics.com | 2014 | Danvers, United States | $53.38M | 14 | Genetic testing products for health risks and traits are offered. | |
| brbiotech.com | 2014 | Guangzhou, China | $203.32M | – | Personalized cancer diagnostics are developed using genomic big data analysis. | |
| lanternpharma.com | 2013 | Dallas, United States | $7.12M | 23 | Drug and companion diagnostics for multi-drug resistant cancers are developed. | |
| novogene.com | 2011 | Beijing, China | $75M | 141 | Genomic services and solutions with NGS expertise are provided. | |
| newhorizonbio.com | 2013 | Beijing, China | $151.83M | – | Provider of early cancer screening and testing services | |
| personalgenome.com | 2010 | Baltimore, United States | $327.45M | 109 | Provider of advanced technology solutions for cancer genome analysis |
Detailed competitors of EvolveGene
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to EvolveGene
10 companies that operate in the same segment as EvolveGene (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about EvolveGene
EvolveGene was founded in 2015.
EvolveGene is headquartered in St. Petersburg, United States. It is registered at St. Petersburg, Florida, United States.
EvolveGene was founded in 2015 and is based in St. Petersburg, United States, within the healthcare sector focused on genetics. Services include male and female fertility tests, assessments for premature ovarian failure risk, carrier screening, and non-invasive prenatal testing. Genetic counseling is provided alongside these offerings to support customers in understanding results and implications. Operations emphasize direct-to-consumer access in reproductive health.
EvolveGene's top competitors include Foundation Medicine, MedGenome and Personalis.
EvolveGene has 1 investor. Key investors include CooperSurgical.
Yes. EvolveGene was acquired by CooperSurgical in April 2018.